JAPAN | MID-NET Programme Uses RWD to Strengthen Early Drug-Safety Signals
Please login to view this page.
INDIA | New ADR-PvPI 2.0 App Broadens Digital Safety Reporting Across Medicines, Vaccines and Devices
Please login to view this page.
GLOBAL | Systematic Review Finds High Non-Reporting of Suspected ADRs to Pharmacovigilance Databases
Please login to view this page.
EU | Revised GVP Module III Strengthens PV Oversight Across NIS, While Imposed-PASS Registration Becomes Legally Binding
Please login to view this page.
US | FDA Advances Digital Pharmacovigilance Modernisation Through New Electronic ICSR Rule and AEMS Public Dashboard
Please login to view this page.
Singapore | HSA Updates Post-Marketing Vigilance Requirements for Therapeutic Products and CTGTPs — Expanding Lifecycle Pharmacovigilance and Safety Reporting Expectations GallerySingapore | HSA Updates Post-Marketing Vigilance Requirements for Therapeutic Products and CTGTPs — Expanding Lifecycle Pharmacovigilance and Safety Reporting Expectations
Singapore | HSA Updates Post-Marketing Vigilance Requirements for Therapeutic Products and CTGTPs — Expanding Lifecycle Pharmacovigilance and Safety Reporting Expectations
Please login to view this page.
EU | EMA Publishes New GVP Module on Pregnancy and Breastfeeding — Implications for Real-World Safety Research
Please login to view this page.
EU | ICH M14 Guideline on Non-Interventional Studies Using RWD Becomes Legally Effective — Implications for EU Pharmacovigilance Practice
Please login to view this page.
EU | Updates to Regulation (EU) No 520/2012 — Key Pharmacovigilance Changes Applicable from 12 February 2026
Please login to view this page.









